Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar
This summary describes the key points of the evaluation, while the Science Evaluation of Proposed Registration Decision PRD2020-09, Fluxapyroxad and Xzemplar provides detailed technical information on the human health, environmental and value assessments of fluxapyroxad and Xzemplar.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Registration Decision PRD2020-09, Fluxapyroxad and XzemplarHTMLEnglish publication HTML
-
Proposed Registration Decision PRD2020-09, Fluxapyroxad and XzemplarHTMLFrench publication HTML
Similar records